Caldas C - Search Results

1

The breast cancer genome--a key for better oncology.

Vollan HK, Caldas C. Vollan HK, et al. Among authors: caldas c. BMC Cancer. 2011 Nov 30;11:501. doi: 10.1186/1471-2407-11-501. BMC Cancer. 2011. PMID: 22128823 Free PMC article. Review.

2

Cancer genes and molecular oncology in the clinic.

Caldas C, Ponder BA. Caldas C, et al. Lancet. 1997 May;349 Suppl 2:SII16-8. doi: 10.1016/s0140-6736(97)90015-5. Lancet. 1997. PMID: 9164442 Review. No abstract available.

3

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis.

Pharoah PD, Day NE, Caldas C. Pharoah PD, et al. Among authors: caldas c. Br J Cancer. 1999 Aug;80(12):1968-73. doi: 10.1038/sj.bjc.6690628. Br J Cancer. 1999. PMID: 10471047 Free PMC article.

4

Molecular profiling of breast cancer: portraits but not physiognomy.

Brenton JD, Aparicio SA, Caldas C. Brenton JD, et al. Among authors: caldas c. Breast Cancer Res. 2001;3(2):77-80. doi: 10.1186/bcr274. Epub 2000 Dec 18. Breast Cancer Res. 2001. PMID: 11250749 Free PMC article. Review.

5

A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.

Huang HE, Chin SF, Ginestier C, Bardou VJ, Adélaïde J, Iyer NG, Garcia MJ, Pole JC, Callagy GM, Hewitt SM, Gullick WJ, Jacquemier J, Caldas C, Chaffanet M, Birnbaum D, Edwards PA. Huang HE, et al. Among authors: caldas c. Cancer Res. 2004 Oct 1;64(19):6840-4. doi: 10.1158/0008-5472.CAN-04-1762. Cancer Res. 2004. PMID: 15466169

6

Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays.

Callagy G, Pharoah P, Chin SF, Sangan T, Daigo Y, Jackson L, Caldas C. Callagy G, et al. Among authors: caldas c. J Pathol. 2005 Feb;205(3):388-96. doi: 10.1002/path.1694. J Pathol. 2005. PMID: 15682439

7

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Brenton JD, Carey LA, Ahmed AA, Caldas C. Brenton JD, et al. Among authors: caldas c. J Clin Oncol. 2005 Oct 10;23(29):7350-60. doi: 10.1200/JCO.2005.03.3845. Epub 2005 Sep 6. J Clin Oncol. 2005. PMID: 16145060 Review.

8

Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.

Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C. Callagy GM, et al. Among authors: caldas c. Clin Cancer Res. 2006 Apr 15;12(8):2468-75. doi: 10.1158/1078-0432.CCR-05-2719. Clin Cancer Res. 2006. PMID: 16638854 Free article.

9

A gene-expression signature to predict survival in breast cancer across independent data sets.

Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C. Naderi A, et al. Among authors: caldas c. Oncogene. 2007 Mar 1;26(10):1507-16. doi: 10.1038/sj.onc.1209920. Epub 2006 Aug 28. Oncogene. 2007. PMID: 16936776

10

A consensus prognostic gene expression classifier for ER positive breast cancer.

Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C. Teschendorff AE, et al. Among authors: caldas c. Genome Biol. 2006;7(10):R101. doi: 10.1186/gb-2006-7-10-r101. Epub 2006 Oct 31. Genome Biol. 2006. PMID: 17076897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page